Akut Solunum Yetmezliği
Özet
Solunum yetmezliği, solunum sisteminin dokular için yeterli oksijeni sağlayamaması ve/veya metabolizma ürünü olan karbondioksiti vücuttan uzaklaştıramaması durumudur. Akut solunum yetmezliği; hipoksemik (Tip 1), hiperkapnik (Tip 2), perioperatif (Tip 3) ve şoka bağlı (Tip 4) olmak üzere dört patofizyolojik grupta sınıflandırılır. Tanılama süreci klinik şüpheyle başlar ve kesin teşhis oda havasında ve istirahat halindeyken yapılan arteriyel kan gazı analizine dayanır. Tedavinin temel amacı doku hipoksisini düzeltmek olup, tanısal işlemlerle eş zamanlı olarak oksijen desteği ve mekanik ventilasyon uygulamalarını içerir. Oksijen tedavisinde hedef, hastanın altındaki patolojiye göre oksijen saturasyonunu (SaO2) %88-98 arasında tutmaktır. Solunum desteğinde, endotrakeal tüp kullanılmadan uygulanan noninvazif mekanik ventilasyon (NIMV), özellikle KOAH alevlenmelerinde ve kardiyojenik pulmoner ödemde mortaliteyi ve entübasyon ihtiyacını azaltmada güçlü bir şekilde önerilmektedir. Uygun şartların bulunmadığı ciddi durumlarda ise invaziv mekanik ventilasyon (İMV) uygulanır. ARDS ve KOAH gibi obstrüktif hastalıklarda ventilatör ilişkili akciğer hasarını önlemek adına koruyucu ventilasyon stratejileri tercih edilmelidir. Başarılı bir yönetim için solunum desteğinin yanı sıra, eşlik eden pnömoni veya sepsis gibi altta yatan nedenlerin de erken dönemde hızla tedavi edilmesi hayat kurtarıcı bir öneme sahiptir.
Respiratory failure occurs when the respiratory system cannot provide adequate oxygen required by tissues and/or fails to eliminate carbon dioxide, a product of metabolism. Pathophysiologically, acute respiratory failure is classified into four groups: hypoxemic (Type 1), hypercapnic (Type 2), perioperative (Type 3), and shock-related (Type 4). The diagnosis begins with clinical suspicion and is confirmed through arterial blood gas analysis performed under room air and at rest. The primary goal of treatment is to correct tissue hypoxia, involving oxygen therapy and mechanical ventilation support simultaneously with diagnostic procedures. In oxygen therapy, the target is to maintain oxygen saturation (SaO2) between 88% and 98% depending on the underlying pathology. Noninvasive mechanical ventilation (NIMV), applied without endotracheal intubation, is strongly recommended for reducing mortality and intubation requirements, particularly in COPD exacerbations and cardiogenic pulmonary edema. In severe cases where suitable conditions are absent, invasive mechanical ventilation (IMV) is utilized. Protective ventilation strategies must be preferred in obstructive diseases like COPD and ARDS to prevent ventilator-induced lung injury. For a successful management, quickly treating the underlying causes such as accompanying pneumonia or sepsis in the early period is lifesaving alongside respiratory support.
Referanslar
Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J Suppl 2003; 47: 3s-14s.
Wood Lawrence DH. The pathophysiology and differential diagnosis of acute respiratory failure. In: Wood Lawrence DH, Hall JB, Schmidt GA, editors. Principles of Critical Care. 3rd ed. McGraw-Hill Education; 2005. p. 417‐26
Hari SM, Mackenzie IMJ. Respiratory failure. Surgery (Oxford) 2007; 25: 380‐7.
Hart N. Respiratory failure. Medicine 2008; 36: 242‐5
Kallstrom TJ. American Association for Respiratory Care (AARC). AARC Clinical Practice Guideline: oxygen therapy for adults in the acute care facility–2002 revision & update. Respir Care 2002; 47: 717-20.
O’Driscoll BR, Howard LS, Davison AG; British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax 2008; 63: vi1-vi68.
Fulmer JD, Snider GL. American College of Chest Physicians (ACCP)–National Heart, Lung, and Blood Institute (NHLBI) Conference on oxygen therapy. Arch Intern Med 1984; 144: 1645-55.
Topeli İskit A, Kayaalp SO. Oksijen ve Diğer Tedavi Gazları. In: Kayaalp O, editor. Akılcı Tedavi Yonunden Tıbbi Farmakoloji. Pelikan Yayıncılık; 2012. p. 641-8.
Ortac Ersoy E, Topeli A. Oksijen Uygulama Sistemleri Yoğun Bakım Derg 2016; 7: 99-105
Nishimura M. High-flow nasal cannula oxygen therapy in adults. J Intensive Care 2015; 3: 15.
Guérin C, Girard R, Chemorin C, et al. Facial mask noninvasive mechanical ventilation reduces the incidence of nosocomial pneumonia. A prospective epidemiological survey from a single ICU.Intensive Care Med 1997; 23:1024-1032.
Hess DR. Noninvasive positive-pressure ventilation and ventilator-associated pneumonia. Respir Care 2005;50: 924-929.
Appendini L, Patessio A, Zanaboni S, et al. Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;149(5): 1069-76. 10.
Ambrosino N, Nava S, Bertone P, et al. Physiologic evaluation of pressure support ventilation by nasal mask in patients with COPD. Chest 1992;101(2):385-391.
Renston JP, DiMarco AF, Supinski GS. Respiratory muscle rest using nasal BİPAP ventilation in patients with stable severe COPD. Chest 1994;105(4):1053-1060.
Calverley PMA. Respiratory failure in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 26s-30s.
Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and care of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-46.
Lightowler JV, Wedzicha JA, Elliot M, Ram SF. Non invasive positive pressure
ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and metaanalysis. BMJ 2003; 326: 185-89.
Rossi A, Appendini L, Roca J. Physiological aspects of noninvasive positive pressure ventilation. Eur Respir Mon 2001; 16: 1-10.
Diaz O, Iglesia R, Ferrer M, et al. Effects of non invasive ventilation on pulmonary gas exchange and hemodynamics during acute hypercapnic exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 1840-45.
Çelikel, TH., M. Sungur, B. Ceyhan ve S. Karakurt, “Comparation of noninvasive positive pressure ventilation with standart medical therapy in hypercapnic acute respiratory failure” Chest, 114, 1636-1642 (1998).
Ferrer M, Esquinas A, Leon M, et al. Noninvasive ventilation in severe hypoxemic respiratory failure. A randomized clinical trial. Am J Respir Crit Care Med 2003; 168:1438-1444.
Consensus conference. Clinical indications for non-invasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD and nocturnal hypoventilation-A concensus conference report. Chest 1999; 116:521-534.
Ouellette DR, Patel S, Girard TD, Morris PE, Schmidt GA, Truwit JD, et al. Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline: Inspiratory Pressure Augmentation During Spontaneous Breathing Trials, Protocols Minimizing Sedation, and Noninvasive Ventilation Immediately After Extubation. Chest 2017; 151: 166-80.
Mollica C., Paone G., Conti V., Ceccarelli D., Schmid G., Mattia P., Perrone N., Petroianni A., Sebastiani A., Cecchini L., Orsetti R., Terzano C. Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis. Respiration. 2010;79(3):209–215. doi: 10.1159/000225932.
Mooney J.J., Raimundo K., Chang E., Broder M.S. Mechanical ventilation in idiopathic pulmonary fibrosis: A nationwide analysis of ventilator use, outcomes, and resource burden. BMC Pulm Med. 2017 doi: 10.1186/s12890-017-0426-2.
Rush B., Wiskar K., Berger L., Griesdale D. The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: A nationwide retrospective cohort analysis. Respir. Med. 2016; 111:72–76. doi: 10.1016/j.rmed.2015.12.005
Gaudry S., Vincent F., Rabbat A., Nunes H., Crestani B., Naccache J.M., Wolff M., Thabut G., Valeyre D., Cohen Y., Mal H. Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia. J. Thorac. Cardiovasc. Surg. 2014;147(1):47–53. doi: 10.1016/j.jtcvs.2013.06.039.
Güngör G., Tatar D., Saltürk C., Çimen P., Karakurt Z., Kirakli C., Adıgüzel N., Ediboglu Ö., Yılmaz H., Moçin Ö.Y., Balcı M., Yılmaz A. Why do patients with interstitial lung diseases fail in the ICU? a 2-center cohort study. Respir. Care. 2013;58(3):525–531. doi: 10.4187/respcare.01734.
Fernández-Pérez E.R., Yilmaz M., Jenad H., Daniels C.E., Ryu J.H., Hubmayr R.D., Gajic O. Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest. 2008;133(5):1113–1119. doi: 10.1378/chest.07-1481.
Zafrani L., Lemiale V., Lapidus N., Lorillon G., Schlemmer B., Azoulay E. Acute Respiratory Failure in Critically Ill Patients with Interstitial Lung Disease. In: Assassi S., editor. PLoS ONE. 8. Vol. 2014. p. e104897.
Akira M., Hamada H., Sakatani M., Kobayashi C., Nishioka M., Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am. J. Roentgenol. 1997;168(1):79–83. doi: 10.2214/ajr.168.1.8976924.
Faverio P, De Giacomi F, Sardella L, Fiorentino G, Carone M, Salerno F, et al. Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights. BMC Pulm Med 2018; 18: 70.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:801-10.
